Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06612554Not ApplicableRecruiting

Zn Supplementation in HIV Immunological Non Responders

Role: collaborator

NCT01813370Completed

A Registry for Patients Treated on the Clinical Trial TAX 3503

Role: collaborator

NCT02620358Not ApplicableCompleted

Two Opposite Strategies of Weaning From Mechanical Ventilation

Role: collaborator

NCT01647230Unknown

Cerebral Oxygenation and Spinal Anaesthesia in Elderly Patients With Hip Fracture

Role: lead

NCT00687336Phase 4Unknown

Helicobacter Pylori Empiric Treatment in Ulcer Bleeding

Role: lead

NCT00144937Phase 4Unknown

Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease

Role: lead

All 6 trials loaded